Hypertension in pregnancy among HIV-infected women in sub-Saharan Africa: prevalence and infant outcomes
- PMID: 20690271
- PMCID: PMC3786365
Hypertension in pregnancy among HIV-infected women in sub-Saharan Africa: prevalence and infant outcomes
Abstract
This analysis was performed to determine the prevalence of hypertension and association of MAP (mean arterial pressure) with birth outcomes among HIV-infected pregnant women not taking antiretrovirals. HIV-infected pregnant women, enrolled into the HPTN024 trial in Tanzania, Malawi and Zambia were followed up at 26-30, 36 weeks, and delivery. The prevalence of hypertension was <1% at both 20-24 weeks and 26-30 weeks and 1.7% by 36 weeks. A 5 mm Hg elevation in MAP increased the risk of stillbirth at 20-24 weeks by 29% (p = 0.001), 32% (p = 0.001) at 26-30 weeks and of low birth weight (LBW) at 36 weeks by 26% (p = 0.001). MAP was not associated with stillbirth at 36 weeks, LBW prior to 36 weeks, preterm birth, neonatal mortality or the risk of maternal to child transmission (MTCT) of HIV.
References
-
- Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) Hypertens Pregnancy. 2001;20:IX–XIV. - PubMed
-
- WHO study group. Hypertensive disorders of pregnancy. Geneva: World Health Organization; 1987. pp. 14–15. Technical report Series No. 758.
-
- Paller MS. Hypertension in pregnancy. J Am Soc Nephrol. 1998 Feb;9(2):314–321. - PubMed
-
- Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066–1074. - PubMed
-
- Urassa DP, Nystrom L, Carlstedt A, et al. Management of hypertension in pregnancy as a quality Indicator of antenatal care in rural Tanzania. Afr J Reprod Hlth. 2003;7(3):69–76. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical